Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Artivion Inc
Nieuws
Artivion Inc
AORT
NYS
: AORT
| ISIN: US2289031005
30/04/2025
23,69 USD
(-1,25%)
(-1,25%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
21 april 2025 ·
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
· Persbericht
4 maart 2025 ·
Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
· Persbericht
8 augustus 2024 ·
Artivion Reports Second Quarter 2024 Financial Results
· Persbericht
5 augustus 2024 ·
Artivion to Participate in Upcoming Investor Conferences
· Persbericht
25 juli 2024 ·
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
· Persbericht
1 juli 2024 ·
Artivion Amends Agreements with Endospan
· Persbericht
6 mei 2024 ·
Artivion Reports First Quarter 2024 Financial Results
· Persbericht
29 april 2024 ·
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
· Persbericht
22 april 2024 ·
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
· Persbericht
1 april 2024 ·
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
· Persbericht
6 maart 2024 ·
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
· Persbericht
15 februari 2024 ·
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
1 februari 2024 ·
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
· Persbericht
29 januari 2024 ·
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
· Persbericht
18 januari 2024 ·
Artivion Obtains $350 Million in Senior Secured Credit Facilities
· Persbericht
6 december 2023 ·
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
· Persbericht
9 november 2023 ·
Artivion Announces Completion of Enrollment in PERSEVERE Trial
· Persbericht
8 november 2023 ·
Artivion to Participate in Upcoming Investor Conferences
· Persbericht
2 november 2023 ·
Artivion Reports Third Quarter 2023 Financial Results
· Persbericht
19 oktober 2023 ·
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe